Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 7, Issue MAY, 2015, Pages

  de Felice, Fernanda G ^a   Lourenco, Mychael V ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Alzheimer's disease; Amyloid oligomers; Endoplasmic reticulum stress; Inflammation; Metabolic stress

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; AMYLOID BETA PROTEIN; INITIATION FACTOR 2ALPHA; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BRAIN METABOLISM; CELL STRESS; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVATION; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC STRESS; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; SYNAPSE; UNFOLDED PROTEIN RESPONSE;

EID: 84931273853     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00094     Document Type: Short Survey

References (117)

1. Bachstetter, A. D., Norris, C. M., Sompol, P., Wilcock, D. M., Goulding, D., Neltner, J. H., et al. (2012). Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology. J. Neurosci. 32, 10201-10210. doi: 10.1523/jneurosci.1496-12.2012
2. Baik, S. H., Cha, M. Y., Hyun, Y. M., Cho, H., Hamza, B., Kim, D. K., et al. (2014). Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol. Aging 35, 1286-1292. doi: 10.1016/j.neurobiolaging.2014.01.003
3. Baleriola, J., Walker, C. A., Jean, Y. Y., Crary, J. F., Troy, C. M., Nagy, P. L., et al. (2014). Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell 158, 1159-1172. doi: 10.1016/j.cell.2014.07.001
4. Barbero-Camps, E., Fernández, A., Baulies, A., Martinez, L., Fernández-Checa, J. C., and Colell, A. (2014). Endoplasmic reticulum stress mediates amyloid beta neurotoxicity via mitochondrial cholesterol trafficking. Am. J. Pathol. 184, 2066-2081. doi: 10.1016/j.ajpath.2014.03.014
5. Bellucci, A., Navarria, L., Zaltieri, M., Falarti, E., Bodei, S., Sigala, S., et al. (2011). Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease. J. Neurochem. 116, 588-605. doi: 10.1111/j.1471-4159.2010.07143.x
6. Bomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J. C., Decker, H., et al. (2012). An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers. J. Clin. Invest. 122, 1339-1353. doi: 10.1172/jci57256
7. Bose, A., Mouton-Liger, F., Paquet, C., Mazot, P., Vigny, M., Gray, F., et al. (2011). Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease. Brain Pathol. 21, 189-200. doi: 10.1111/j.1750-3639.2010.00437.x
8. Buffington, S. A., Huang, W., and Costa-Mattioli, M. (2014). Translational control in synaptic plasticity and cognitive dysfunction. Annu. Rev. Neurosci. 37, 17-38. doi: 10.1146/annurev-neuro-071013-014100
9. Calay, E. S., and Hotamisligil, G. S. (2013). Turning off the inflammatory, but not the metabolic, flames. Nat. Med. 19, 265-267. doi: 10.1038/nm.3114
10. Casas-Tinto, S., Zhang, Y., Sanchez-Garcia, J., Gomez-Velazquez, M., Rincon-Limas, D. E., and Fernandez-Funez, P. (2011). The ER stress factor XBP1s prevents amyloid- neurotoxicity. Hum. Mol. Genet. 20, 2144-2160. doi: 10.1093/hmg/ddr100
11. Chafekar, S. M., Hoozemans, J. J. M., Zwart, R., Baas, F., and Scheper, W. (2007). Aβ1-42induces mild endoplasmic reticulum stress in an aggregation State-dependent manner. Antioxid. Redox Signal. 9, 2245-2254. doi: 10.1089/ars.2007.1797
12. Chang, R., Suen, K.-C., Ma, C.-H., Elyaman, W., Ng, H.-K., and Hugon, J. (2002a). Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 83, 1215-1225. doi: 10.1046/j.1471-4159.2002.01237.x
13. Chang, R. C., Wong, A. K., Ng, H. K., and Hugon, J. (2002b). Phosphorylation of eukaryotic initiation factor 2 alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13, 2429-2432. doi: 10.1097/00001756-200212200-00011
14. Chen, Z., and Zhong, C. (2013). Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog. Neurobiol. 108, 21-43. doi: 10.1016/j.pneurobio.2013.06.004
15. Colla, E., Coune, P., Liu, Y., Pletnikova, O., Troncoso, J. C., Iwatsubo, T., et al. (2012). Endoplasmic reticulum stress is important for the manifestations of a-synucleinopathy in vivo. J. Neurosci. 32, 3306-3320. doi: 10.1523/jneurosci.5367-11.2012
16. Combs, C. K. (2009). Inflammation and microglia actions in Alzheimer's disease. J. Neuroimmune Pharmacol. 4, 380-388. doi: 10.1007/s11481-009-9165-3
17. Costa-Mattioli, M., Gobert, D., Harding, H., Herdy, B., Azzi, M., Bruno, M., et al. (2005). Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 436, 1166-1173. doi: 10.1038/nature03897
18. Costa-Mattioli, M., Gobert, D., Stern, E., Gamache, K., Colina, R., Cuello, C., et al. (2007). eIF2a phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 129, 195-206. doi: 10.1016/j.cell.2007.01.050
19. Craft, S. (2012). Alzheimer disease: insulin resistance and AD-extending the translational path. Nat. Rev. Neurol. 8, 360-362. doi: 10.1038/nrneurol.2012.112
20. Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., et al. (2013). Glucose levels and risk of dementia. N. Engl. J. Med. 369, 540-548. doi: 10.1056/NEJMoa1215740
21. De Felice, F. G. (2013). Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J. Clin. Invest. 123, 531-539. doi: 10.1172/JCI64595
22. De Felice, F. G., and Ferreira, S. T. (2014). Inflammation, defective insulin signaling and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 63, 2262-2272. doi: 10.2337/db13-1954
23. De Felice, F. G., Lourenco, M. V., and Ferreira, S. T. (2014). How does brain insulin resistance develop in Alzheimer's disease? Alzheimers Dement. 10, S26-S32. doi: 10.1016/j.jalz.2013.12.004
24. De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., et al. (2007). Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 11590-11601. doi: 10.1074/jbc.m607483200
25. de la Monte, S. (2009). Insulin resistance and Alzheimer's disease. BMB Rep. 42, 475-481. doi: 10.5483/BMBRep.2009.42.8.475
26. Devi, L., and Ohno, M. (2010). Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS One 5:e12974. doi: 10.1371/journal.pone.0012974
27. Devi, L., and Ohno, M. (2014). PERK mediates eIF2alpha phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease. Neurobiol. Aging 35, 2272-2281. doi: 10.1016/j.neurobiolaging.2014.04.031
28. Dhawan, G., Floden, A. M., and Combs, C. K. (2012). Amyloid-β oligomers stimulate microglia through a tyrosine kinase mechanism. Neurobiol. Aging 33, 2247-2261. doi: 10.1016/j.neurobiolaging.2011.10.027
29. Di Prisco, G. V., Huang, W., Buffington, S. A., Hsu, C. C., Bonnen, P. E., Placzek, A. N., et al. (2014). Translational control of mGluR-dependent long-term depression and object-place learning by eIF2alpha. Nat. Neurosci. 17, 1073-1082. doi: 10.1038/nn.3754
30. Ferreira, S. T., Clarke, J. R., Bomfim, T. R., and De Felice, F. G. (2014). Inflammation, defective insulin signaling and neuronal dysfunction in Alzheimer's disease. Alzheimers Dement. 10(1 Suppl), S76-S83. doi: 10.1016/j.jalz.2013.12.010
31. Ferreira, S. T., and Klein, W. L. (2011). The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol. Learn. Mem. 96, 529-543. doi: 10.1016/j.nlm.2011.08.003
32. Flexner, L. B., Flexner, J. B., Roberts, R. B., and De La Haba, G. (1964). Loss of recent memory in mice as related to regional inhibition of cerebral protein synthesis. Proc. Natl. Acad. Sci. U S A 52, 1165-1169. doi: 10.1073/pnas.52.5.1165
33. Floden, A. M., and Combs, C. K. (2006). Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J. Neurosci. 26, 4644-4648. doi: 10.1523/jneurosci.4822-05.2006
34. Forny-Germano, L., Lyra E Silva, N. M., Batista, A. F., Brito-Moreira, J., Gralle, M., Boehnke, S. E., et al. (2014). Alzheimer's disease-like pathology induced by amyloid-beta oligomers in nonhuman primates. J. Neurosci. 34, 13629-13643. doi: 10.1523/JNEUROSCI.1353-14.2014
35. Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., et al. (2003). Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U S A 100, 10417-10422. doi: 10.1073/pnas.1834302100
36. Gregor, M. F., and Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445. doi: 10.1146/annurev-immunol-031210-101322
37. Halliday, M., Radford, H., Sekine, Y., Moreno, J., Verity, N., Le Quesne, J., et al. (2015). Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell Death Dis. 6:e1672. doi: 10.1038/cddis.2015.49
38. Heneka, M. T., Golenbock, D. T., and Latz, E. (2015). Innate immunity in Alzheimer's disease. Nat. Immunol. 16, 229-236. doi: 10.1038/ni.3102
39. Hensley, K., Floyd, R. A., Zheng, N.-Y., Nael, R., Robinson, K. A., Nguyen, X., et al. (1999). p38 kinase is activated in the Alzheimer's disease brain. J. Neurochem. 72, 2053-2058. doi: 10.1046/j.1471-4159.1999.0722053.x
40. Herrup, K. (2010). Reimagining Alzheimer's disease-an age-based hypothesis. J. Neurosci. 30, 16755-16762. doi: 10.1523/JNEUROSCI.4521-10.2010
41. Hetz, C. (2012). The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89-102. doi: 10.1038/nrm3270
42. Hetz, C., Chevet, E., and Harding, H. P. (2013). Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 12, 703-719. doi: 10.1038/nrd3976
43. Hetz, C., and Mollereau, B. (2014). Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233-249. doi: 10.1038/nrn3689
44. Hetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., et al. (2009). XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 23, 2294-2306. doi: 10.1101/gad.1830709
45. Hoozemans, J. J. M., Van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., and Scheper, W. (2009). The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174, 1241-1251. doi: 10.2353/ajpath.2009.080814
46. Hoozemans, J. J. M., Veerhuis, R., Haastert, E. S., Rozemuller, J. M., Baas, F., Eikelenboom, P., et al. (2005). The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 110, 165-172. doi: 10.1007/s00401-005-1038-0
47. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature 444, 860-867. doi: 10.1038/nature05485
48. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M. (1995). Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415. doi: 10.1172/jci117936
49. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271, 665-668. doi: 10.1126/science.271.5249.665
50. Hoyer, S., Oesterreich, K., and Wagner, O. (1988). Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J. Neurol. 235, 143-148. doi: 10.1007/bf00314304
51. Kalmijin, S., Launer, L. J., Ott, A., Witteman, J. C., Hofman, A., and Breteler, M. M. (1997). Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann. Neurol. 42, 776-782. doi: 10.1002/ana.410420514
52. Kapogiannis, D., and Mattson, M. P. (2011). Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 10, 187-198. doi: 10.1016/S1474-4422(10)70277-5
53. Kim, H.-J., Raphael, A. R., Ladow, E. S., Mcgurk, L., Weber, R. A., Trojanowski, J. Q., et al. (2013). Therapeutic modulation of eIF2a phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 46, 152-160. doi: 10.1038/ng.2853
54. Kiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., and Ikezu, T. (2010). CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J. 24, 3093-3102. doi: 10.1096/fj.10-155317
55. Kleinridders, A., Cai, W., Cappellucci, L., Ghazarian, A., Collins, W. R., Vienberg, S. G., et al. (2015). Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc. Natl. Acad. Sci. U S A 112, 3463-3468. doi: 10.1073/pnas.1500877112
56. Lai, E., Teodoro, T., and Volchuk, A. (2007). Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology (Bethesda) 22, 193-201. doi: 10.1152/physiol.00050.2006
57. Lajole, P., and Snapp, E. L. (2011). Changes in BiP availability reveal hypersensitivity to acute endoplasmic reticulum stress in cells expressing mutant huntingtin. J. Cell Sci. 124, 3332-3343. doi: 10.1242/jcs.087510
58. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., et al. (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U S A 95, 6448-6453. doi: 10.1073/pnas.95.11.6448
59. Lange, P. S., Chavez, J. C., Pinto, J. T., Coppola, G., Sun, C. W., Townes, T. M., et al. (2008). ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J. Exp. Med. 205, 1227-1242. doi: 10.1084/jem.20071460
60. Ledo, J. H., Azevedo, E. P., Clarke, J. R., Ribeiro, F. C., Figueiredo, C. P., Foguel, D., et al. (2013). Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice. Mol. Psychiatry 18, 1053-1054. doi: 10.1038/mp.2012.168
61. Lee, D. Y., Lee, K.-S., Lee, H. J., Kim, D. H., Noh, Y. H., Yu, K., et al. (2010). Activation of PERK signaling attenuates Abeta-mediated ER stress. PloS One 5:e10489. doi: 10.1371/journal.pone.0010489
62. Lourenco, M. V., Clarke, J. R., Frozza, R. L., Bomfim, T. R., Forny-Germano, L., Batista, A. F., et al. (2013). TNF-a mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. Cell Metab. 18, 831-843. doi: 10.1016/j.cmet.2013.11.002
63. Lourenco, M. V., and Ledo, J. H. (2013). Targeting Alzheimer's pathology through PPAR? signaling: modulation of microglial function. J. Neurosci. 33, 5083-5084. doi: 10.1523/JNEUROSCI.0172-13.2013
64. Ma, T., Trinh, M. A., Wexler, A. J., Bourbon, C., Gatti, E., Pierre, P., et al. (2013). Suppression of eIF2a kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat. Neurosci. 16, 1299-1305. doi: 10.1038/nn.3486
65. Ma, Q. L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., et al. (2009). β-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 29, 9078-9089. doi: 10.1523/JNEUROSCI.1071-09.2009
66. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., Mcdonald, B. L., and Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc. Natl. Acad. Sci. U S A 82, 4245-4249. doi: 10.1073/pnas.82.12.4245
67. Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., et al. (2010). Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama Study. Neurology 75, 764-770. doi: 10.1212/wnl.0b013e3181eee25f
68. Mattson, M. P. (2008). Hormesis defined. Ageing Res. Rev. 7, 1-7. doi: 10.1016/j.arr.2007.08.007
69. Mattson, M. P. (2012). Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab. 16, 706-722. doi: 10.1016/j.cmet.2012.08.012
70. McAlpine, F. E., Lee, J., Harms, A. S., Ruhn, K. A., Blurton-Jones, M., Hong, J., et al. (2009). Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol. Dis. 34, 163-177. doi: 10.1016/j.nbd.2009.01.006
71. Medeiros, R., Prediger, R. D. S., Passos, G. F., Pandolfo, P., Duarte, F. S., Franco, J. L., et al. (2007). Connecting TNF-a signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid-β protein. J. Neurosci. 27, 5394-5404. doi: 10.1523/jneurosci.5047-06.2007
72. Medinas, D. B., and Hetz, C. (2013). Proteostasis impairment: at the intersection between Alzheimer's disease and diabetes. Cell Metab. 18, 771-772. doi: 10.1016/j.cmet.2013.11.009
73. Mitsuda, T., Hayakawa, Y., Itoh, M., Ohta, K., and Nakagawa, T. (2007). ATF4 regulates gamma-secretase activity during amino acid imbalance. Biochem. Biophys. Res. Commun. 352, 722-727. doi: 10.1016/j.bbrc.2006.11.075
74. Moloney, A. M., Griffin, R. J., Timmons, S., O'connor, R., Ravid, R., and O'neill, C. (2010). Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging 31, 224-243. doi: 10.1016/j.neurobiolaging.2008.04.002
75. Monson, N. L., Ireland, S. J., Ligocki, A. J., Chen, D., Rounds, W. H., Li, M., et al. (2014). Elevated CNS inflammation in patients with preclinical Alzheimer's disease. J. Cereb. Blood Flow Metab. 34, 30-33. doi: 10.1038/jcbfm.2013.183
76. Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., et al. (2013). Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5:206ra138. doi: 10.1126/scitranslmed.3006767
77. Moreno, J. A., Radford, H., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., et al. (2012). Sustained translational repression by eIF2a-P mediates prion neurodegeneration. Nature 485, 507-511. doi: 10.1038/nature11058
78. Morris, G. P., Clark, I. A., and Vissel, B. (2014). Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta Neuropathol. Commun. 2:135. doi: 10.1186/s40478-014-0135-5
79. Mouton-Liger, F., Paquet, C., Dumurgier, J., Bouras, C., Pradier, L., Gray, F., et al. (2012a). Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2a pathway. Biochimica et Biophysica Acta (BBA) - Mol. Basis Dis. 1822, 885-896. doi: 10.1016/j.bbadis.2012.01.009
80. Mouton-Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J.-L., et al. (2012b). Increased cerebrospinal fluid levels of double-stranded RNA-dependent protein kinase in Alzheimer's disease. Biol. Psychiatry 71, 829-835. doi: 10.1016/j.biopsych.2011.11.031
81. Mucke, L., and Selkoe, D. J. (2012). Neurotoxicity of amyloid-beta protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2:a006338. doi: 10.1101/cshperspect.a006338
82. Nakamura, T., Kunz, R. C., Zhang, C., Kimura, T., Yuan, C. L., Baccaro, B., et al. (2015). A critical role for PKR complexes with TRBP in immunometabolic regulation and eIF2alpha phosphorylation in obesity. Cell Rep. 11, 295-307. doi: 10.1016/j.celrep.2015.03.021
83. Nisticò, R., Cavallucci, V., Piccinin, S., Macrì, S., Pignatelli, M., Mehdawy, B., et al. (2012). Insulin receptor β-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory. Neuromolecular Med. 14, 262-269. doi: 10.1007/s12017-012-8184-z.
84. O'Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., et al. (2008). Phosphorylation of the translation initiation factor eIF2a increases BACE1 levels and promotes amyloidogenesis. Neuron 60, 988-1009. doi: 10.1016/j.neuron.2008.10.047
85. O'Neill, C. (2013). PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease. Exp. Gerontol. 48, 647-653. doi: 10.1016/j.exger.2013.02.025
86. Ott, A., Stolk, R. P., Hofman, A., Van Harskamp, F., Grobbee, D. E., and Breteler, M. M. B. (1996). Association of diabetes mellitus and dementia: the rotterdam study. Diabetologia 39, 1392-1397. doi: 10.1007/s001250050588
87. Ott, A., Stolk, R. P., Van Harskamp, F., Pols, H. A. P., Hofman, A., and Breteler, M. M. B. (1999). Diabetes mellitus and the risk of dementia: the rotterdam study. Neurology 53, 1937-1937. doi: 10.1212/wnl.53.9.1937
88. Ounallah-Saad, H., Sharma, V., Edry, E., and Rosenblum, K. (2014). Genetic or pharmacological reduction of perk enhances cortical-dependent taste learning. J. Neurosci. 34, 14624-14632. doi: 10.1523/jneurosci.2117-14.2014
89. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A. H., Iwakoshi, N. N., Ozdelen, E., et al. (2004). Endoplasmic reticulum stress links obesity, insulin action and type 2 diabetes. Science 306, 457-461. doi: 10.1126/science.1103160
90. Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., et al. (2006). Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140. doi: 10.1126/science.1128294
91. Pan, X. D., Zhu, Y. G., Lin, N., Zhang, J., Ye, Q. Y., Huang, H. P., et al. (2011). Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease. Mol. Neurodegener. 6:45. doi: 10.1186/1750-1326-6-45
92. Paquet, C., Mouton-Liger, F., Meurs, E. F., Mazot, P., Bouras, C., Pradier, L., et al. (2011). The PKR activator PACT is induced by Aβ: involvement in Alzheimer's disease. Brain Pathol. 22, 219-229. doi: 10.1111/j.1750-3639.2011.00520.x.
93. Parajuli, B., Sonobe, Y., Horiuchi, H., Takeuchi, H., Mizuno, T., and Suzumura, A. (2013). Oligomeric amyloid beta induces IL-1beta processing via production of ROS: implication in Alzheimer's disease. Cell Death Dis. 4:e975. doi: 10.1038/cddis.2013.503
94. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., and Ferri, C. P. (2013). The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 9, 63.e2-75.e2. doi: 10.1016/j.jalz.2012.11.007
95. Rajasethupathy, P., Antonov, I., Sheridan, R., Frey, S., Sander, C., Tuschl, T., et al. (2012). A role for neuronal pirnas in the epigenetic control of memory-related synaptic plasticity. Cell 149, 693-707. doi: 10.1016/j.cell.2012.02.057
96. Raven, J. F., and Koromilas, A. E. (2008). PERK and PKR: old kinases learn new tricks. Cell Cycle 7, 1146-1150. doi: 10.4161/cc.7.9.5811
97. Ricobaraza, A., Cuadrado-Tejedor, M., Marco, S., Pérez-Otaño, I., and García-Osta, A. (2010). Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 22, 1040-1050. doi: 10.1002/hipo.20883
98. Ricobaraza, A., Cuadrado-Tejedor, M., Perez-Mediavilla, A., Frechilla, D., Del Rio, J., and Garcia-Osta, A. (2009). Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 34, 1721-1732. doi: 10.1038/npp.2008.229
99. Roffé, M., Hajj, G. N., Azevedo, H. F., Alves, V. S., and Castilho, B. A. (2013). IMPACT is a developmentally regulated protein in neurons that opposes the eukaryotic initiation factor 2alpha kinase GCN2 in the modulation of neurite outgrowth. J. Biol. Chem. 288, 10860-10869. doi: 10.1074/jbc.m113.461970
100. Rossato, J. I., Bevilaqua, L. R., Myskiw, J. C., Medina, J. H., Izquierdo, I., and Cammarota, M. (2007). On the role of hippocampal protein synthesis in the consolidation and reconsolidation of object recognition memory. Learn. Mem. 14, 36-46. doi: 10.1101/lm.422607
101. Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., et al. (2004). Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U S A 101, 3100-3105. doi: 10.1073/pnas.0308724101
102. Segev, Y., Michaelson, D. M., and Rosenblum, K. (2012). ApoE e4 is associated with eIF2a phosphorylation and impaired learning in young mice. Neurobiol. Aging 34, 863-872. doi: 10.1016/j.neurobiolaging.2012.06.020
103. Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science 298, 789-791. doi: 10.1126/science.1074069
104. Sondag, C. M., Dhawan, G., and Combs, C. K. (2009). Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J. Neuroinflammation 6:1. doi: 10.1186/1742-2094-6-1
105. Steen, E., Terry, B. M., Rivera, E. J., Cannon, J. L., Neely, T. R., Tavares, R., et al. (2005). Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J. Alzheimers Dis. 7, 63-80.
106. Stern, E., Chinnakkaruppan, A., David, O., Sonenberg, N., and Rosenblum, K. (2013). Blocking the eIF2a kinase (PKR) enhances positive and negative forms of cortex-dependent taste memory. J. Neurosci. 33, 2517-2525. doi: 10.1523/JNEUROSCI.2322-12.2013
107. Talbot, K., Wang, H., Kazi, H., Han, L., Bakshi, K. P., Stucky, A., et al. (2012). Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation and cognitive decline. J. Clin. Invest. 122, 1316-1338. doi: 10.1172/JCI59903
108. Vallerie, S. N., and Hotamisligil, G. S. (2010). The role of JNK proteins in metabolism. Sci. Transl. Med. 2:60rv65. doi: 10.1126/scitranslmed.3001007
109. van der Harg, J. M., Nölle, A., Zwart, R., Boerema, A. S., Van Haastert, E. S., Strijkstra, A. M., et al. (2014). The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress. Cell Death Dis. 5:e1393. doi: 10.1038/cddis.2014.354
110. Viola, K. L., and Klein, W. L. (2015). Amyloid beta oligomers in Alzheimer's disease pathogenesis, treatment and diagnosis. Acta Neuropathol. 129, 183-206. doi: 10.1016/j.bpj.2014.11.1128
111. Wang, R., Li, J. J., Diao, S., Kwak, Y. D., Liu, L., Zhi, L., et al. (2013). Metabolic stress modulates Alzheimer's beta-secretase gene transcription via SIRT1-PPARgamma-PGC-1 in neurons. Cell Metab. 17, 685-694. doi: 10.1016/j.cmet.2013.03.016
112. Wiley, J. C., Pettan-Brewer, C., and Ladiges, W. C. (2011). Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice. Aging Cell 10, 418-428. doi: 10.1111/j.1474-9726.2011.00680.x
113. Xia, W., Yang, T., Shankar, G. M., Smith, I. M., Shen, Y., Walsh, D., et al. (2009). A specific enzyme-linked immunosorbent assay for measuring β-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch. Neurol. 66, 190-199. doi: 10.1001/archneurol.2008.565
114. Yamanaka, M., Ishikawa, T., Griep, A., Axt, D., Kummer, M. P., and Heneka, M. T. (2012). PPAR?/RXRa-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. J. Neurosci. 32, 17321-17331. doi: 10.1523/JNEUROSCI.1569-12.2012
115. Yang, Y. M., Shang, D. S., Zhao, W. D., Fang, W. G., and Chen, Y. H. (2013). Microglial TNF-alpha-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration. Neurochem. Res. 38, 2295-2304. doi: 10.1007/s11064-013-1138-5
116. Yoon, S. O., Park, D. J., Ryu, J. C., Ozer, H. G., Tep, C., Shin, Y. J., et al. (2012). JNK3 perpetuates metabolic stress induced by Aβ peptides. Neuron 75, 824-837. doi: 10.3410/f.717965605.793466623
117. Zhu, P. J., Huang, W., Kalikulov, D., Yoo, J. W., Placzek, A. N., Stoica, L., et al. (2011). Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition. Cell 147, 1384-1396. doi: 10.1016/j.cell.2011.11.029